Auspex Pharmaceuticals' Series B Round

Auspex Pharmaceuticals raised a round of funding on May 14, 2008.

Auspex Pharmaceuticals is a privately held biopharmaceutical company focused on the use of deuterium in medicinal chemistry, and the treatment of hyperkinetic movement disorders including Huntington's…

Articles about Auspex Pharmaceuticals' Series B Round: